arrow
M

Miljan Kuljanin

flare therapeutics inc.
H指数:19
被引数:2,346

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Covalent PPARγ inverse agonism by FX-909 reveals mechanistic insights into therapeutic targeting of PPARγ/RXRα-activated urothelial carcinoma

FX-909通过共价PPARγ反向激动作用揭示靶向PPARγ/RXRα激活的尿路上皮癌的机制性见解

2026-05-280
OAAI
De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer

从头嘧啶生物合成抑制与BCL-XL靶向在胰腺癌中协同作用

2025-07-300
OA
Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling

Yap-tead缔合的共价干扰物抑制了有缺陷的河马信号

2022-10-2733
OA
Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in Pancreatic Cancer

协调的转录和分解代谢程序支持胰腺癌中铁依赖性适应ras-mapk途径抑制

2022-06-3038
OA
NCOA4-Mediated Ferritinophagy Is a Pancreatic Cancer Dependency via Maintenance of Iron Bioavailability for Iron-Sulfur Cluster Proteins
2022-06-3065
OAAI
Multiomic analysis on human cell model of wolfram syndrome reveals changes in mitochondrial morphology and function

wolfram综合征人类细胞模型的多组学分析揭示了线粒体形态和功能的变化

2021-11-209
OAAI
Selective Modulation of a Pan-Essential Protein as a Therapeutic Strategy in Cancer
2021-04-2124
OA
Discovery of a selective inhibitor of doublecortin like kinase 1
2020-04-0685
OAAI